1-5 of 5
Hiroshi Kimura
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

mTOR Inhibitors Induce Cell-Cycle Arrest and Inhibit Tumor Growth in Epstein–Barr Virus–Associated T and Natural Killer Cell Lymphoma Cells

Free
Jun-ichi Kawada, Yoshinori Ito, Seiko Iwata, Michio Suzuki, Yoshihiko Kawano, Tetsuhiro Kanazawa, Mohammed Nure Alam Siddiquey, Hiroshi Kimura
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (21): 5412–5422.
https://doi.org/10.1158/1078-0432.CCR-13-3172
Published: 30 October 2014
View articletitled, mTOR Inhibitors Induce Cell-Cycle Arrest and Inhibit Tumor Growth in Epstein–Barr Virus–Associated T and Natural Killer Cell Lymphoma Cells
Open the PDF for mTOR Inhibitors Induce Cell-Cycle Arrest and Inhibit Tumor Growth in Epstein–Barr Virus–Associated T and Natural Killer Cell Lymphoma Cells in another window
Includes: Supplementary data
Journal Articles

Anti-CCR4 Monoclonal Antibody Mogamulizumab for the Treatment of EBV-Associated T- and NK-Cell Lymphoproliferative Diseases

Free
Tetsuhiro Kanazawa, Yutaka Hiramatsu, Seiko Iwata, Mohammed Siddiquey, Yoshitaka Sato, Michio Suzuki, Yoshinori Ito, Fumi Goshima, Takayuki Murata, Hiroshi Kimura
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (19): 5075–5084.
https://doi.org/10.1158/1078-0432.CCR-14-0580
Published: 30 September 2014
View articletitled, Anti-CCR4 Monoclonal Antibody Mogamulizumab for the Treatment of EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
Open the PDF for Anti-CCR4 Monoclonal Antibody Mogamulizumab for the Treatment of EBV-Associated T- and NK-Cell Lymphoproliferative Diseases in another window
Includes: Supplementary data
Journal Articles

Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type

Free
Yoshinori Ito, Hiroshi Kimura, Yoshinobu Maeda, Chizuko Hashimoto, Fumihiro Ishida, Koji Izutsu, Noriyasu Fukushima, Yasushi Isobe, Jun Takizawa, Yuichi Hasegawa, Hajime Kobayashi, Seiichi Okamura, Hikaru Kobayashi, Motoko Yamaguchi, Junji Suzumiya, Rie Hyo, Shigeo Nakamura, Keisei Kawa, Kazuo Oshimi, Ritsuro Suzuki
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (15): 4183–4190.
https://doi.org/10.1158/1078-0432.CCR-12-1064
Published: 30 July 2012
View articletitled, Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type
Open the PDF for Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type in another window
Includes: Supplementary data
Journal Articles

AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor

Free
Masayuki Takeda, Tokuzo Arao, Hideyuki Yokote, Teruo Komatsu, Kazuyoshi Yanagihara, Hiroki Sasaki, Yasuhide Yamada, Tomohide Tamura, Kazuya Fukuoka, Hiroshi Kimura, Nagahiro Saijo, Kazuto Nishio
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (10): 3051–3057.
https://doi.org/10.1158/1078-0432.CCR-06-2743
Published: 15 May 2007
View articletitled, AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor
Open the PDF for AZD2171 Shows Potent Antitumor Activity Against Gastric Cancer Over-Expressing Fibroblast Growth Factor Receptor 2/Keratinocyte Growth Factor Receptor in another window
Journal Articles

Mina53 as a Potential Prognostic Factor for Esophageal Squamous Cell Carcinoma

Free
Makoto Tsuneoka, Hiromasa Fujita, Nobuyuki Arima, Kwesi Teye, Torahiko Okamura, Hiroki Inutsuka, Yoshiro Koda, Kazuo Shirouzu, Hiroshi Kimura
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (21): 7347–7356.
https://doi.org/10.1158/1078-0432.CCR-03-0543
Published: 08 November 2004
View articletitled, Mina53 as a Potential Prognostic Factor for Esophageal Squamous Cell Carcinoma
Open the PDF for Mina53 as a Potential Prognostic Factor for Esophageal Squamous Cell Carcinoma in another window